In 2025, Jazz Pharmaceuticals reported a basic net loss per share of 5.84 U.S. dollars, a significant decrease compared to the previous two years. Jazz Pharmaceuticals is a biopharma company originally from California and now based in Ireland.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Jazz Pharmaceuticals, & U.S. Securities and Exchange Commission. (February 24, 2026). Net income per share of Jazz Pharmaceuticals from 2016 to 2025 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/1266789/net-income-per-share-of-jazz-pharmaceuticals/
Jazz Pharmaceuticals, und U.S. Securities and Exchange Commission. "Net income per share of Jazz Pharmaceuticals from 2016 to 2025." Chart. February 24, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/1266789/net-income-per-share-of-jazz-pharmaceuticals/
Jazz Pharmaceuticals, U.S. Securities and Exchange Commission. (2026). Net income per share of Jazz Pharmaceuticals from 2016 to 2025. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/1266789/net-income-per-share-of-jazz-pharmaceuticals/
Jazz Pharmaceuticals, and U.S. Securities and Exchange Commission. "Net Income per Share of Jazz Pharmaceuticals from 2016 to 2025." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 24 Feb 2026, /statistics/1266789/net-income-per-share-of-jazz-pharmaceuticals/
Jazz Pharmaceuticals & U.S. Securities and Exchange Commission, Net income per share of Jazz Pharmaceuticals from 2016 to 2025 ÌÇÐÄÆƽâ°æ, /statistics/1266789/net-income-per-share-of-jazz-pharmaceuticals/ (last visited July 28, 2026)
Net income per share of Jazz Pharmaceuticals from 2016 to 2025 [Graph], Jazz Pharmaceuticals, & U.S. Securities and Exchange Commission, February 24, 2026. [Online]. Available: /statistics/1266789/net-income-per-share-of-jazz-pharmaceuticals/
